IMAX Corporation (IMAX) has released an update.
Auxly Cannabis Group Inc. reports a record-breaking first quarter in 2024, with a 5% revenue increase to $25.2 million and a significant improvement in adjusted EBITDA, up 1523% to $2.2 million. The company also achieved a record 38% gross margin on finished cannabis inventory sold. These milestones reflect Auxly’s focus on product quality, innovation, and operational efficiency, driving profitable growth and maintaining a strong market position in the Canadian recreational cannabis sector.
For further insights into IMAX stock, check out TipRanks’ Stock Analysis page.
